Pharmacodynamic Study to Compare Acute Effects of Dihydroergotamine Mesylate (DHE) on Pulmonary Arterial Pressure

NCT01089062 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MAP0004
DRUG: IV Placebo (Saline)
DRUG: Placebo Inhaler
DRUG: IV Dihydroergotamine Mesylate (DHE)

Sponsor

Allergan

Collaborators

[object Object]